| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 04/15/2004 | US20040072868 Liver disorders; anticholesterol agents; cardiovascular disorders |
| 04/15/2004 | US20040072867 Antiemetics, antidepressants, anxiolytic agents, antitussive agents |
| 04/15/2004 | US20040072866 Condensation, dehydration; factor x inhibitors |
| 04/15/2004 | US20040072865 Anticholesterol agents; antidiabetic agents; antilipemic agents |
| 04/15/2004 | US20040072840 Analgesics, antiinflammatory agents, antiallergens, autoimmune disease, cardiovascular disorders |
| 04/15/2004 | US20040072802 Antiarthritic agents; antiulcer agents; bone disorders; antitumor agents; oral diseases |
| 04/15/2004 | US20040071654 Delivering labile agents; buffering effect; transfecting nucleic acids; nontoxic |
| 04/15/2004 | DE10248067A1 New N-diaminophenylpropyl- or N-heteroarylpropyl-piperazine or piperidine derivatives, useful as dopaminergic and/or serotoninergic agents for e.g. treating Parkinson's disease or schizophrenia |
| 04/15/2004 | CA2501243A1 Piperidine derivatives as ccr5 inhibitors |
| 04/15/2004 | CA2500966A1 Novel sulphones for inhibition of gamma secretase |
| 04/15/2004 | CA2500869A1 Spiro compounds, medicinal compositions containing the same and intermediates of the compounds |
| 04/15/2004 | CA2500672A1 Piperazine and piperidine derivatives for treatment of neurological diseases |
| 04/15/2004 | CA2500664A1 4-aminopiperidine derivatives, processes for their preparation and their use as medicaments |
| 04/14/2004 | EP1408037A1 Novel diarylmethylpiperazine and diarylmethylphenyl compounds with analgesic effect |
| 04/14/2004 | EP1407773A1 A process for the preparation of s (-) amlodipine salts |
| 04/14/2004 | EP1406866A1 Inhibitors of the ice/ced-3 family of cysteine proteases |
| 04/14/2004 | EP1406626A2 Sulphonyl aryl hydroxamates and their use as mmp inhibitors |
| 04/14/2004 | EP1406624A2 Process for the preparation of paroxetine substantially free of alkoxy impurities |
| 04/14/2004 | EP1406623A1 Substituted 1-phenethylpiperidine compounds used as inter alia analgesics |
| 04/14/2004 | EP1406622A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 04/14/2004 | EP1406602A2 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 04/14/2004 | EP1214299B1 Muscarinic antagonists |
| 04/14/2004 | EP1062206B1 Amino anthracyclinone derivatives and their use in the treatment of amyloidosis |
| 04/14/2004 | CN1489578A 3-(3-amidinophenyl)-5-[({[1-(iminoethyl)4-piperidyl} amino)methyl] benzoic acid dihydrochloride and process for preparing same |
| 04/14/2004 | CN1489575A Benzamidine derivatives and process for producing same |
| 04/14/2004 | CN1489573A Perfluoronated cycle-containing tertiary amines used as basis for gas-conveying emulsions and preparation method |
| 04/14/2004 | CN1145612C New 1-aza-2-alkyl-6-aryl-cyclanes compound, its producing process and medical composition containing them |
| 04/14/2004 | CN1145483C Levobupivacaine and its use as an anaesthetic in pregnant women |
| 04/13/2004 | US6720338 Bcl-x1 inhibiting compositions and methods of promoting apoptosis in a mammal |
| 04/13/2004 | US6720336 4,4-biarylpiperidine derivatives |
| 04/13/2004 | US6720324 Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof |
| 04/13/2004 | US6720319 Compounds useful as reversible inhibitors of cysteine proteases |
| 04/08/2004 | WO2004029156A1 Thermoplastic compositions with enhanced melt flow and compatibility |
| 04/08/2004 | WO2004029041A1 Novel piperidine derivatives for use in the treatment of chemokine mediated disease states |
| 04/08/2004 | WO2004028530A1 N-substituted heterocyclic amines as modulators of chemokine receptor activity |
| 04/08/2004 | WO2003053326B1 Enantiomers of n-(2,6-dimethylphenyl)-1-propyl-2-piperidinocarboxamide; its pharmaceutical compositions and processes of making them |
| 04/08/2004 | WO2003051276B1 Therapeutic heterocycles |
| 04/08/2004 | WO2003027068A3 Substituted amines for the treatment of neurological disorders |
| 04/08/2004 | WO2001087839A8 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity |
| 04/08/2004 | US20040068112 Process for the preparation diaryl-4-amino-piperidinyl compounds |
| 04/08/2004 | US20040067988 Anticoagulants |
| 04/08/2004 | US20040067979 N-bridged selective androgen receptor modulators and methods of use thereof |
| 04/08/2004 | US20040067972 Acetylcholinesterase inhibitor; Alzheimer's disease; cognition activators; central nervous system disorders |
| 04/08/2004 | US20040067961 Organ grafting; antiarthritic agents; inflammatory bowel disease |
| 04/08/2004 | US20040067935 N-substituted heterocyclic amines as modulators of chemokine receptor activity |
| 04/08/2004 | US20040067256 Novel modified release formulation |
| 04/08/2004 | US20040067252 Novel modified release formulation |
| 04/08/2004 | CA2497280A1 Novel piperidine derivatives for use in the treatment of chemokine mediated disease states |
| 04/08/2004 | CA2496989A1 Thermoplastic compositions with enhanced melt flow and compatibility |
| 04/07/2004 | EP1404667A1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 04/07/2004 | EP1404650A1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments |
| 04/07/2004 | EP1404369A1 Composition comprising a pde-4 inhibitor and h1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment of respiratory diseases |
| 04/07/2004 | EP1404326A2 Method of treating parkinson's disease |
| 04/07/2004 | EP1404325A2 Method for treating nerve injury caused by surgery |
| 04/07/2004 | EP0973512B1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 04/07/2004 | EP0836511B1 Device for transdermal electrotransport delivery of fentanyl and sufentanil |
| 04/07/2004 | CN1487923A Process for the preparation of (3-cyano-1H-indol-7-yl) (4-(4-fluorophenethyl)piperazin-1-yl)-methanone and salts thereof |
| 04/07/2004 | CN1487817A Primary intermediates for oxidative coloration of hair |
| 04/07/2004 | CN1144793C Polar-substituted hydrocarbons |
| 04/07/2004 | CN1144789C Pyrrolidine and piperidine derivatives, producing process and application thereof |
| 04/07/2004 | CN1144784C Diphenyl alkyl-tetrahydropyridines, process for their preparation, and pharmaceutical composition containing them |
| 04/06/2004 | US6716986 Metabolites of the 5ht2a antagonist (+)- alpha -(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethanol, preparation and intermediates |
| 04/06/2004 | US6716985 Alcoholism, psychological disorders |
| 04/06/2004 | US6716861 Heterocyclic 1,2,4-oxadiazole or oxazole ring containing propanohydroxamic acids useful as antiscarring agent |
| 04/06/2004 | US6716854 Treatments for restless legs syndrome |
| 04/06/2004 | US6716846 High affinity ligands for nociceptin receptor ORL-1 |
| 04/06/2004 | US6716844 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 04/06/2004 | CA2060616C Use of 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine derivatives as free radical scavengers |
| 04/01/2004 | WO2004026834A1 Crystalline organic acid salt of amlodipine |
| 04/01/2004 | WO2004026833A1 Cyclic amine compound, process for producing the same, and use |
| 04/01/2004 | WO2004026832A1 Urea compound and use thereof |
| 04/01/2004 | WO2004026823A1 Amide and sulfonamide ligands for the estrogen receptor |
| 04/01/2004 | WO2004026816A1 Aromatic liver x-receptor modulators |
| 04/01/2004 | WO2004005478A3 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 04/01/2004 | WO2003099819A3 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics |
| 04/01/2004 | WO2003084943A3 Terphenyl derivatives, preparation thereof, compositions containing same |
| 04/01/2004 | WO2003084540A3 Compositions comprising mmp7 modulators for the treatment of chronic pain |
| 04/01/2004 | WO2003075853A3 Cyclic derivatives as modulators of chemokine receptor activity |
| 04/01/2004 | US20040063955 Antichoelsterol agents; cardiovascular disorders; antihistamines; multiple sclerosis; antihistamines |
| 04/01/2004 | US20040063953 Method of producing N-alkoxycarbonylpiperidine derivative, new compound as raw material therefor, and method of producing the compound |
| 04/01/2004 | US20040063940 3,3-Biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 04/01/2004 | US20040063932 Stable free nitroxyl radicals as oxidation catalysts and process for oxidation |
| 04/01/2004 | US20040063783 Used to treat pathologies characterized by an oxidative stress condition and a lack of availability of endothelial nitrogen monoxide, such as ischemia, restenosis, erectile dysfunction, hypoxia, transplant rejection and diabetes |
| 04/01/2004 | US20040063760 Sodium channel modulatiors |
| 04/01/2004 | US20040063759 Administering to a mammal, for treatment or prevention of conditions that can be treated or prevented by antagonizing the CCR1 receptor in a mammal, a piperidinone compound |
| 04/01/2004 | US20040063753 N-acetoamino-4-one-Pyridine derivatives are used as Lp-PLA2 (lipoprotein Associated Phospholipase A2) enzyme inhibitor |
| 04/01/2004 | US20040063748 Such as 2-(4-amino-2,3,5-trimethylphenoxy)-N-methyl-N-(4-piperidinyl)acetamide which has neuroprotective effects by inducing calcium binding proteins |
| 04/01/2004 | US20040063725 Binding neuropeptide Y receptors; hypertension, angina, atherosclerosis, depression, anxiety, inflammation, allergies |
| 04/01/2004 | US20040063723 One pot synthesis; formylation, oximination, cyanation, saponification and amidation of indole ester |
| 04/01/2004 | US20040063701 Potent and specific serotonin 2 receptor inhibition with low adverse side effects; such as 1-formyl-N-(2-(4-(5H-dibenzo-(a,d)cyclohepten-5-ylidene)-1 -piperidinyl))ethylisonipecot-amide |
| 04/01/2004 | US20040063686 Diabetes, major depression, manic depression, anxiety, schizophrenia, sleep disorders |
| 04/01/2004 | US20040063684 Treatment of oesophageal motility disorders and gastro-oesophageal reflux disease |
| 04/01/2004 | US20040063679 Amidino and guanidino peptidyl compounds; autoimmune diseases |
| 04/01/2004 | US20040063677 Omega monounsaturated fatty acid derivativatized biologically active materials; drug delivery; drug resistance; bioavail-ability |
| 04/01/2004 | US20040063671 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 04/01/2004 | US20040063643 Bombesin antagonists |
| 04/01/2004 | US20040063609 Used for preparation of information-rich single enantiomer compound libraries |
| 04/01/2004 | US20040061039 Furnace mount and method of installation |
| 04/01/2004 | CA2499490A1 Amide and sulfonamide ligands for the estrogen receptor |
| 04/01/2004 | CA2499213A1 Aromatic liver x-receptor modulators |